Thyroglobulin measurement before rhTSH-aided 131I ablation in detecting metastases from differentiated thyroid carcinoma

被引:56
作者
Giovanella, Luca [1 ,2 ,3 ]
Ceriani, Luca [1 ,2 ]
Suriano, Sergio [3 ]
Ghelfo, Antonella [4 ]
Maffioli, Marco [5 ]
机构
[1] Oncol Inst So Switzerland, Dept Nucl Med, CH-6500 Bellinzona, Switzerland
[2] Oncol Inst So Switzerland, Thyroid Unit, CH-6500 Bellinzona, Switzerland
[3] Ente Osped Cantonale, Dept Clin Chem & Lab Med, CH-6500 Bellinzona, Switzerland
[4] Univ Hosp Fdn Macchi, Dept Nucl Med, I-21100 Varese, Italy
[5] Univ Hosp Fdn Macchi, Dept ENT Head & Neck Surg, I-21100 Varese, Italy
关键词
D O I
10.1111/j.1365-2265.2008.03244.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim Thyroidectomy followed by administration of large activities of 131-iodine (I-131) is the treatment of choice for differentiated thyroid carcinoma (DTC). The serum thyroglobulin (Tg) measurement during hypothyroidism (offT4-Tg), just before radioiodine thyroid ablation, has proved to be effective for predicting persistent/recurrent disease. However, the Tg measurement cannot be used as a corresponding value for pre-ablative offT4-Tg when recombinant human TSH (rhTSH) is used as stimulus before treatment. The present study was undertaken to evaluate if post-thyroidectomy Tg values, measured before rhTSH-stimulated radioiodine ablation is of prognostic value in patients affected by DTC. Methods We enrolled 126 patients with DTC submitted to total thyroidectomy. T4 treatment was started just after surgery to suppress TSH levels and Tg levels (onT4-Tg) were measured just before rhTSH-aided thyroid ablation by I-131 (3700 MBq). Neck radioiodine uptake (RAIU) was measured just before ablation and a post-treatment whole body scan (PT-WBS) was performed. Results A significant relationship was found between thyroid remnants' RAIU and onT4-Tg levels (P < 0.001). The 1.10 ng/ml onT4-Tg threshold selected by ROC curve analysis identifies patients with positive PT-WBS with 83.3% sensitivity, 65.7% specificity, 44.5% positive predictive value (PPV) and 93.6% negative predictive value (NPV). The 0.65 ng/ml cut-off level recognizes metastatic patients with 82.9% sensitivity, 55.2% specificity, 43.3% PPV and 97.8% NPV when compared with 12 months restaging results. Among 63 patients with initially undetectable onT4-Tg (i.e. <= 0.2 ng/ml) none had positive PT-WBS nor DTC relapse at 12-month restaging (NPV 100%). Conclusions Based on our data we conclude that pre-ablative onT4-Tg is a prognostic marker and should be used instead of pre-ablative TSH-stimulated Tg measurement when rhTSH-aided radioiodine ablation is done.
引用
收藏
页码:659 / 663
页数:5
相关论文
共 15 条
[1]  
BECKER W, 1994, EXP CLIN ENDOCR S3, V102, P1
[2]   Role of thyroglobulin measurement in fine-needle aspiration biopsies of cervical lymph nodes in patients with differentiated thyroid cancer [J].
Frasoldati, A ;
Toschi, E ;
Zini, M ;
Flora, M ;
Caroggio, A ;
Dotti, C ;
Valcavi, R .
THYROID, 1999, 9 (02) :105-111
[3]   Thyroglobulin assay 4 weeks after thyroidectomy predicts outcome in low-risk papillary thyroid carcinoma [J].
Giovanella, L ;
Ceriani, L ;
Ghelfo, A ;
Keller, F .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2005, 43 (08) :843-847
[4]   Thyroglobulin assay during thyroxine treatment in low-risk differentiated thyroid cancer management: comparison with recombinant human thyrotropin-stimulated assay and imaging procedures [J].
Giovanella, Luca ;
Ceriani, Luca ;
Ghelfo, Antonella ;
Keller, Franco ;
Sacchi, Andrea ;
Maffioli, Marco ;
Spriano, Giuseppe .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2006, 44 (05) :648-652
[5]  
Grunwald F, 1996, J NUCL MED, V37, P1962
[6]   Serum thyroglobulin measurement: clinical background and main methodological aspects with clinical impact [J].
Iervasi, A. ;
Iervasi, G. ;
Carpi, A. ;
Zucchelli, G. C. .
BIOMEDICINE & PHARMACOTHERAPY, 2006, 60 (08) :414-424
[7]   Serum thyroglobulin levels at the time of 131I remnant ablation just after thyroidectomy are useful for early prediction of clinical recurrence in low-risk patients with differentiated thyroid carcinoma [J].
Kim, TY ;
Kim, WB ;
Kim, ES ;
Ryu, JS ;
Yeo, JS ;
Kim, SC ;
Hong, SJ ;
Shong, YK .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (03) :1440-1445
[8]   Evaluation of the diagnostic value of the first thyroglobulin determination in detecting metastases after differentiated thyroid carcinoma surgery [J].
Makarewicz, J. ;
Adamczewski, Z. ;
Knapska-Kucharska, M. ;
Lewinski, A. .
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2006, 114 (09) :485-489
[9]  
Morgenthaler NG, 2002, CLIN CHEM, V48, P1077
[10]   Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: Results of an international, randomized, controlled study [J].
Pacini, F ;
Ladenson, PW ;
Schlumberger, M ;
Driedger, A ;
Luster, M ;
Kloos, RT ;
Sherman, S ;
Haugen, B ;
Corone, C ;
Molinaro, E ;
Elisei, R ;
Ceccarelli, C ;
Pinchera, A ;
Wahl, RL ;
Leboulleux, S ;
Ricard, M ;
Yoo, J ;
Busaidy, NL ;
Delpassand, E ;
Hanscheid, H ;
Felbinger, R ;
Lassmann, M ;
Reiners, C .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (03) :926-932